Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating

被引:19
|
作者
Vinkers, Christiaan H.
Risbrough, Victoria B.
Geyer, Mark A.
Caldwell, Sorana
Low, Malcolm J.
Hauger, Richard L.
机构
[1] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, San Diego Vet Affairs Healthcare Syst, La Jolla, CA 92093 USA
[3] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Psychopharmacol, Utrecht, Netherlands
[4] Oregon Hlth & Sci Univ, Ctr Study Weight Regulat, Portland, OR 97201 USA
[5] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA
关键词
CRH (corticotropin-releasing hormone); CRF; dopamine; haloperidol; SCH23390; prepulse inhibition; startle; knockout mice;
D O I
10.1016/j.pbb.2007.01.018
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Corticotropin-releasing factor (CRF), a neuropeptide released during stress, has been reported to modulate startle behavior, including reducing the threshold for acoustic startle responding and reducing prepulse inhibition (PPI). The central mechanisms mediating CRF system regulation of startle and PPI are still unclear. Some antipsychotic drugs attenuate CRF-induced deficits in PPI in rats and mice. Here we tested the hypothesis that indirect activation of DA(1)-receptors (D-1) and DA(2)-receptors (D-2) contributes to the effects of CRF on PPI. We compared the effect of central administration of h/r-CRF (0.2-0.6 nmol) on PPI in mice with either a D-1 or D-2 receptor null mutation (knockout, KO) or in mice pretreated with D-1, or D-2 receptor antagonists SCH23390 (1 mg/kg) or haloperidol (1 mg/kg). D-1, and D-2 KO mice exhibited no significant differences in their sensitivity to CRF-induced disruptions of PPI. Similarly, neither SCH23390 nor haloperidol pretreatment altered the CRF-induced disruption in PPI, although both increased PPI at baseline. CRF-induced increases in startle also remained unchanged by any of the DA receptor manipulations. These results indicate that neither D-1-nor D-2-receptor activation is necessary for CRF to exert its effects on acoustic startle and PPI in mice. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:550 / 558
页数:9
相关论文
共 50 条
  • [1] Is dopamine to blame for CRF-induced sensorimotor gating deficits in rats?
    Hammer, RP
    Arrillaga-Romany, IC
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S44 - S44
  • [2] INTERACTION OF FLUNARIZINE WITH DOPAMINE D2 AND D1 RECEPTORS
    AMBROSIO, C
    STEFANINI, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 197 (2-3) : 221 - 223
  • [3] The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating
    Frau, Roberto
    Mosher, Laura J.
    Bini, Valentina
    Pillolla, Giuliano
    Pes, Romina
    Saba, Pierluigi
    Fanni, Silvia
    Devoto, Paola
    Bortolato, Marco
    PSYCHONEUROENDOCRINOLOGY, 2016, 63 : 59 - 67
  • [4] The involvement of dopamine in nociception:: the role of D1 and D2 receptors in the dorsolateral striatum
    Magnusson, JE
    Fisher, K
    BRAIN RESEARCH, 2000, 855 (02) : 260 - 266
  • [5] Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats
    Seki, S
    Igawa, Y
    Kaidoh, K
    Ishizuka, O
    Nishizawa, O
    Andersson, KE
    NEUROUROLOGY AND URODYNAMICS, 2001, 20 (01) : 105 - 113
  • [6] In vivo dopamine agonist properties of rotigotine: Role of D1 and D2 receptors
    Fenu, Sandro
    Espa, Elena
    Pisanu, Augusta
    Di Chiara, Gaetano
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 788 : 183 - 191
  • [7] Differential role of dopamine D1 and D2 receptors in isoniazid-induced vacuous chewing movements
    Naidu, PS
    Kulkarni, SK
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2000, 22 (10): : 747 - 751
  • [8] D1 AND D2 DOPAMINE-RECEPTORS IN THE RAT STRIATUM
    SZMIGIELSKI, A
    ZALEWSKAKASZUBSKA, J
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (04) : 1418 - 1419
  • [9] Contribution of dopamine D1 and D2 receptors to amygdala activity
    Takahashi, H.
    Otsuka, T.
    Takano, H.
    Kodaka, F.
    Kikyo, H.
    Arakawa, R.
    Miyoshi, M.
    Okumura, M.
    Ito, H.
    Suhara, T.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 : S109 - S109
  • [10] Disruption of the dopamine D1/D2 heteromer using synthetic peptides
    Champion, Margaret
    Baraka, Adam
    Evans, Hedeel
    Heyl-Clegg, Deborah
    FASEB JOURNAL, 2017, 31